The actions have raised questions about why it took public pressure before the companies altered their programs.

Politicians and Big Pharma find themselves in a tough spot as public pressure forces deeper digging into drug pricing policies.

Blue Cross Blue Shield is urging Congress to boost the ACA marketplace by increasing subsidies and putting in place a reinsurance program.

Executives expressed support for eliminating drug rebates, increasing price transparency and shifting to a more value-based pricing system.